Finance

Lists
PHIA:AMS
Koninklijke Philips NV
€23.61
-0.51%
(-0.12) 1D
Aug 21, 5:35:17 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHIA...
Open
€23.62
High
€23.70
Low
€23.30
Mkt. cap
23.04B
Avg. vol.
1.85M
Volume
1.13M
Dividend
3.60%
Quarterly dividend
€0.21
Ex-dividend date
May 12, 2025
P/E ratio
20.38
52-wk high
€27.70
52-wk low
€20.90
EPS
€1.16
Shares outstanding
982.88M
No. of employees
64K
Open
€23.62
High
€23.70
Low
€23.30
Mkt. cap
23.04B
Avg. vol.
1.85M
Volume
1.13M
Dividend
3.60%
Quarterly dividend
€0.21
Ex-dividend date
May 12, 2025
P/E ratio
20.38
52-wk high
€27.70
52-wk low
€20.90
EPS
€1.16
Shares outstanding
982.88M
No. of employees
64K
News stories
From web sources and news partners
Profile
Koninklijke Philips N.V., commonly known as Philips, is a Dutch multinational health technology company and former major consumer electronics manufacturer. The company was founded in Eindhoven in 1891 by Gerard Philips and his father Frederik Philips to manufacture incandescent light bulbs. In October 1997, Philips decided to move its corporate headquarters from Eindhoven to Amsterdam, with the relocation beginning the following year. The company's headquarters remain in Amsterdam. Philips was awarded the Dutch Royal designation by Queen Wilhelmina in 1916; Koninklijke became part of the company name in 1998. Through the 20th century, Philips developed into a large electronics conglomerate, producing products ranging from kitchen appliances and electric shavers to lighting equipment and televisions. Philips introduced the compact cassette format, which became a widely adopted standard for tape recording. The company later collaborated with Sony in developing the compact disc standard. Philips also became a major participant in the entertainment industry through its controlling interest in PolyGram, which it sold to Seagram in 1998. Wikipedia
About Koninklijke Philips NV
CEORoy Jakobs
Employees63.7K
FoundedMay 15, 1891
HeadquartersAmsterdam, North Holland, Netherlands
SectorMedical device
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.30B
5.10B
3.90B
4.36B
Cost of goods sold
2.39B
2.81B
2.14B
2.21B
Cost of revenue
2.39B
2.81B
2.14B
2.21B
Research and development expenses
414.00M
427.00M
394.00M
484.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.18B
1.32B
1.18B
1.21B
Operating expense
1.58B
1.74B
1.52B
1.54B
Total operating expenses
3.97B
4.55B
3.66B
3.75B
Operating income
329.00M
547.00M
241.00M
610.00M
Other non operating income
1.00M
1.00M
1.00M
-1.00M
EBT including unusual items
275.00M
467.00M
190.00M
546.00M
EBT excluding unusual items
275.00M
517.00M
190.00M
546.00M
Income tax expense
87.00M
74.00M
44.00M
160.00M
Effective tax rate
31.64%
15.85%
23.16%
29.30%
Other operating expenses
-11.00M
-8.00M
-54.00M
-151.00M
Net income
184.00M
395.00M
151.00M
384.00M
Net profit margin
4.28%
7.75%
3.87%
8.81%
Earnings per share
0.36
0.60
-
-
Interest and investment income
21.00M
11.00M
35.00M
33.00M
Interest expense
-78.00M
-33.00M
-83.00M
-95.00M
Net interest expenses
-57.00M
-22.00M
-48.00M
-62.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
632.00M
826.00M
506.00M
991.00M
Gain or loss from assets sale
-1.00M
25.00M
13.00M
-93.00M
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps